Slovenian recommendations for the detection and treatment of venous thrombosis
Abstract
* no abstract
Downloads
References
Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep vein thrombosis within a defned population. J Intern Med. 1992; 232 (2): 155–60.
Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verifed by necropsy over 30 years. BMJ. 1991; 302: 709–11.
Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, et al. Determinants and time course of the postthrombotic syndrome afer acute deep venous thrombosis. Ann Intern Med. 2008; 149 (10): 698–707.
Chong LY, Fenu E, Stansby G, Hodgkinson S. Guideline Development Group. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ. 2012; 344: e3979.
Wells PS. Advances in the diagnosis of venous thromboembolism. J Tromb Trombolysis. 2006; 21 (1): 31–40.
Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Trombosis. N Engl J Med. 2003; 349 (13): 1227–35.
Scarvelis D, Wells PS. Diagnosis and treatment of deep-vein thrombosis. CMAJ. 2006; 175 (9): 1087–92.
Righini M, Paris S, Le Gal G, Laroche JP, Perrier A, Bounameaux H. Clinical relevance of distal deep vein thrombosis. Review of literature data. Tromb Haemost. 2006; 95 (1): 56–64.
Palareti G, Schellong S. Isolated distal deep vein thrombosis: what we know and what we are doing. J Tromb Haemost. 2012; 10 (1): 11–9.
Singh K, Yakoub D, Giangola P, DeCicca M, Patel CA, Marzouk F, et al. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis. J Vasc Surg. 2012; 55 (1): 136–40.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber S, et al. Antithrombotic therapy for VTE: Antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition). Chest. 2012; 141: e419S–e94S.
MacDonald PS, Kahn SR, Miller N, Obrand D. Short term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg. 2003; 37 (3): 523–7.
Schellong SM. Distal DVT: worth diagnosing? Yes. J Tromb Haemost. 2007; 5 (1): 51–54.
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO. VTE, Trombophilia, Antithrombotic Terapy, and Pregnancy: Antithrombotic Terapy and Prevention of Trombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th edition). Chest. 2012; 141: e691S–e736S.
Heijboer H, Jongbloets LM, Büller HR, Lensing AW, ten Cate JW. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radiol. 1992; 33 (4): 297–300.
Aguilar C, del Villar V. Combined D-dimer and clinical probability are useful for exclusion of recurrent deep venous thrombosis. Am J Hematol. 2007; 82 (1): 41–4.
Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, SimioniP, et al. A simple ultrasoundapproach for detection of recurrent proximal-veinthrombosis. Circulation. 1993; 88: 1730–5.
Engelberger RP, Kucher N. Management of deep vein thrombosis of the upper extremity. Circulation. 2012; 126 (6): 768–73.
Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation. 2004; 110 (5): 566–70.
Constans J, Salmi LR, Sevestre-Pietri MA, Perusat S, Nguon M, Degeilh M, et al. A clinical prediction score for upper extremity deep venous thrombosis. Tromb Haemost. 2008; 99 (1): 202–7.
Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, et al. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med. 2014; 160 (7): 451–7.
Vižintin Cuderman T. Štalc M. Venski trombembolizmi In: Mavri A, Vene N, eds. Priročnik za uporabo novih peroralnih antikoagulacijskih zdravil v klinični praksi. Ljubljana: Slovensko zdravniško društvo, Sekcija za antikoagulacijsko zdravljenje in preprečevanje trombemboličnih bolezni pri Združenju za žilne bolezni; 2012. p. 48–62.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Terapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016; 149 (2): 315–52.
Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral Anticoagulants: Antithrombotic Terapy and Prevention of Trombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (9th edition). Chest. 2012; 141 (2 Suppl); e24S–e43.
Tratar G, Mavri A, Gubenšek M, Krevel B, Ježovnik MK, Ostaševski N, et al. Antikoagulacijsko zdravljenje pri bolnikih z zmanjšanim ledvičnim delovanjem. Zdravn Vestn. 2008; 77 (4): 299–305.
Hirsh J, Raschke R. Heparin and Low-Molecular-Weight Heparin: Te Seventh ACCP Conference on Antithrombotic and Trombolytic Terapy FREE TO VIEW. Chest. 2004; 126 (3): 188S–203S.
Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of veonus thromboembolism in patients with cancer. J Tromb Haemost. 2013; 11 (1): 56–70.
EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010; 363 (26): 2499–510.
EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012; 366 (14): 1287–-97.
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013; (8): 709–18.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013; 369 (9): 799–808.
Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, Mercuri M, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013; 369 (15): 1406–15.
Mavri A. Nova peroralna antikoagulacijska zdravila. In: Mavri A, Vene N, eds. Priročnik za uporabo novih peroralnih antikoagulacijskih zdravil v klinični praksi. Ljubljana: Slovensko zdravniško društvo, Sekcija za antikoagulacijsko zdravljenje in preprečevanje trombemboličnih bolezni pri Združenju za žilne bolezni; 2012. p. 5–20.
Lee AY. Treatment of established thrombotic events in patients with cancer. Tromb Res. 2012; 129 (1): S146–53.
Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Tromb Trombolysis. 2016; 41 (1): 32–67.
Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, et al. CaVenT Study Group. Long-term outcome afer additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012; 379 (9810): 31–8.
Watson L, Broderick C, Armon MP. Trombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2014; 1: CD002783.
Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, et al. Treatment and Prevention of Heparin-Induced Trombocytopenia: Antithrombotic Terapy and Prevention of Trombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141; e495S–e530S.
Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014; 383: 880–8.
O’Shaughnessy D, Miles J, Wimperis J. UK patients with deep-vein thrombosis can be safely treated as out-patients. Q J Med. 2000; 93: 663–7.
Dunn AS, Coller B. Outpatient treatment of deep vein thrombosis: translating clinical trials into practice. Am J Med. 1999; 106: 660–9.
Ježovnik M, Štalc M. Obravnava bolnika z vensko trombozo v dnevni bolnišnici. In: Fras Z, Poredoš P, eds. Zbornik prispevkov. Ljubljana: Medicinska fakulteta, Katedra za interno medicino, 2013. p. 255–260.
Mavri A. Vižintin Cuderman T, Štalc M, Božič M, Tratar G, Gubenšek M et al. Priporočila za določanje testov tromboflije pri bolnikih z vensko trombembolijo. Zdravn Vestn. 2013; 82 (2): 65–79.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
